Karydas Daphne
CIK: 0001816952•Chief Financial Officer
Officer
Primary company: Mineralys Therapeutics, Inc. (MLYS)
Karydas Daphne is a corporate insider (Chief Financial Officer) at Mineralys Therapeutics, Inc. (MLYS) filing SEC Form 4 transactions. 21 transactions across 4 companies, totaling $0 in purchases and $689,797 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 3,000 | $12.02 | $36K | 38,000 | 6/17/2026 Filed: 6/17/2026 | Filing → | |
| Sale | 3,000 | $25.00 | $75K | 6,200 | 6/17/2026 Filed: 6/17/2026 | Filing → | |
| Exercise | 3,000 | $12.02 | $36K | 9,200 | 6/17/2026 Filed: 6/17/2026 | Filing → | |
| Award | 21,110 | $11.85 | $250K | 21,110 | 5/27/2026 Filed: 5/27/2026 | Filing → | |
| Exercise | 3,000 | $12.02 | $36K | 41,000 | 3/31/2026 Filed: 4/2/2026 | Filing → | |
| Sale | 3,000 | $25.00 | $75K | 6,200 | 3/31/2026 Filed: 4/2/2026 | Filing → | |
| Exercise | 3,000 | $12.02 | $36K | 9,200 | 3/31/2026 Filed: 4/2/2026 | Filing → | |
| Award | 8,300 | $28.06 | $233K | 8,300 | 2/19/2026 Filed: 2/19/2026 | Filing → | |
| Award | 6,200 | - | - | 6,200 | 2/19/2026 Filed: 2/19/2026 | Filing → | |
| Exercise | 15,000 | - | - | 17,900 | 11/13/2025 Filed: 11/13/2025 | Filing → | |
| Sale | 4,885 | $46.36 | $226K | 0 | 11/13/2025 Filed: 11/13/2025 | Filing → | |
| Sale | 10,115 | $45.81 | $463K | 4,885 | 11/13/2025 Filed: 11/13/2025 | Filing → | |
| Exercise | 15,000 | $10.20 | $153K | 15,000 | 11/13/2025 Filed: 11/13/2025 | Filing → | |
| Award | 26,000 | - | - | 26,000 | 6/12/2025 Filed: 6/13/2025 | Filing → | |
| Award | 32,900 | $10.20 | $336K | 32,900 | 2/13/2025 Filed: 2/24/2025 | Filing → | |
| Award | 22,000 | - | - | 22,000 | 5/22/2024 Filed: 5/23/2024 | Filing → | |
| Award | 26,000 | - | - | 26,000 | 5/9/2024 Filed: 5/13/2024 | Filing → | |
| Award | 52,000 | $0.00 | $0 | 52,000 | 9/18/2023 Filed: 9/20/2023 | Filing → | |
| Award | 44,000 | $0.00 | $0 | 44,000 | 9/13/2023 Filed: 9/14/2023 | Filing → | |
LogicBio Therapeutics, Inc. LOGC | Disposition | 12,500 | - | - | 0 | 11/16/2022 Filed: 11/17/2022 | Filing → |
Type
Exercise
Shares
3,000
Price
$12.02
Value
$36K
Type
Sale
Shares
3,000
Price
$25.00
Value
$75K
Type
Exercise
Shares
3,000
Price
$12.02
Value
$36K
Type
Award
Shares
21,110
Price
$11.85
Value
$250K
Type
Exercise
Shares
3,000
Price
$12.02
Value
$36K
Type
Sale
Shares
3,000
Price
$25.00
Value
$75K
Type
Exercise
Shares
3,000
Price
$12.02
Value
$36K
Type
Award
Shares
8,300
Price
$28.06
Value
$233K
Type
Award
Shares
6,200
Price
-
Value
-
Type
Exercise
Shares
15,000
Price
-
Value
-
Type
Sale
Shares
4,885
Price
$46.36
Value
$226K
Type
Sale
Shares
10,115
Price
$45.81
Value
$463K
Type
Exercise
Shares
15,000
Price
$10.20
Value
$153K
Type
Award
Shares
26,000
Price
-
Value
-
Type
Award
Shares
32,900
Price
$10.20
Value
$336K
Type
Award
Shares
22,000
Price
-
Value
-
Type
Award
Shares
26,000
Price
-
Value
-
Type
Award
Shares
52,000
Price
$0.00
Value
$0
Type
Award
Shares
44,000
Price
$0.00
Value
$0
LogicBio Therapeutics, Inc.
LOGC
Type
Disposition
Shares
12,500
Price
-
Value
-
AI Agent
Try asking...